Bicara Therapeutics (BCAX) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.6
-1.18
-0.75
-0.33

Details

Expected EPS
-0.554043
Actual EPS
-0.5
Surprise EPS
0.05
Surprise Percent
+9.75%

Description

Bicara Therapeutics (BCAX) has reported earnings of -0.5 per share for Q3 2025.

0 Comments

Share your thoughts